10X GENOMICS (Germany) Buy Hold or Sell Recommendation
| 1KJ Stock | EUR 14.11 0.49 3.36% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding 10X GENOMICS DL is 'Strong Sell'. Macroaxis provides 10X GENOMICS buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 1KJ positions.
Check out 10X GENOMICS Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in 10X Stock please use our How to Invest in 10X GENOMICS guide. Note, we conduct extensive research on individual companies such as 10X and provide practical buy, sell, or hold advice based on investors' constraints. 10X GENOMICS DL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
10X |
Execute 10X GENOMICS Buy or Sell Advice
The 10X recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on 10X GENOMICS DL. Macroaxis does not own or have any residual interests in 10X GENOMICS DL or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute 10X GENOMICS's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
10X GENOMICS Trading Alerts and Improvement Suggestions
| 10X GENOMICS DL generated a negative expected return over the last 90 days | |
| 10X GENOMICS DL has high historical volatility and very poor performance | |
| The company reported the revenue of 503.71 M. Net Loss for the year was (504.02 M) with profit before overhead, payroll, taxes, and interest of 416.4 M. | |
| 10X GENOMICS DL has accumulated about 621.96 M in cash with (219.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.66. | |
| Over 100.0% of the company shares are owned by institutions such as pension funds |
10X GENOMICS current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. 10X analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. 10X analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
10X GENOMICS Returns Distribution Density
The distribution of 10X GENOMICS's historical returns is an attempt to chart the uncertainty of 10X GENOMICS's future price movements. The chart of the probability distribution of 10X GENOMICS daily returns describes the distribution of returns around its average expected value. We use 10X GENOMICS DL price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of 10X GENOMICS returns is essential to provide solid investment advice for 10X GENOMICS.
| Mean Return | -0.42 | Value At Risk | -7.78 | Potential Upside | 8.01 | Standard Deviation | 5.33 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of 10X GENOMICS historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
10X GENOMICS Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to 10X GENOMICS or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that 10X GENOMICS's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a 10X stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.68 | |
β | Beta against Dow Jones | 2.07 | |
σ | Overall volatility | 5.36 | |
Ir | Information ratio | -0.1 |
10X GENOMICS Volatility Alert
10X GENOMICS DL exhibits very low volatility with skewness of 0.24 and kurtosis of 3.81. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure 10X GENOMICS's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact 10X GENOMICS's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.10X GENOMICS Fundamentals Vs Peers
Comparing 10X GENOMICS's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze 10X GENOMICS's direct or indirect competition across all of the common fundamentals between 10X GENOMICS and the related equities. This way, we can detect undervalued stocks with similar characteristics as 10X GENOMICS or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of 10X GENOMICS's fundamental indicators could also be used in its relative valuation, which is a method of valuing 10X GENOMICS by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare 10X GENOMICS to competition |
| Fundamentals | 10X GENOMICS | Peer Average |
| Return On Equity | -0.21 | -0.31 |
| Return On Asset | -0.0892 | -0.14 |
| Profit Margin | (0.33) % | (1.27) % |
| Operating Margin | (0.28) % | (5.51) % |
| Shares Outstanding | 95.6 M | 571.82 M |
| Shares Owned By Insiders | 2.60 % | 10.09 % |
| Shares Owned By Institutions | 99.56 % | 39.21 % |
| Revenue | 503.71 M | 9.43 B |
| Gross Profit | 416.4 M | 27.38 B |
| EBITDA | (117.15 M) | 3.9 B |
| Net Income | (504.02 M) | 570.98 M |
| Cash And Equivalents | 621.96 M | 2.7 B |
| Cash Per Share | 5.66 X | 5.01 X |
| Total Debt | 70.82 M | 5.32 B |
| Debt To Equity | 0.09 % | 48.70 % |
| Current Ratio | 6.69 X | 2.16 X |
| Book Value Per Share | 6.78 X | 1.93 K |
| Cash Flow From Operations | (219.4 M) | 971.22 M |
| Earnings Per Share | (0.76) X | 3.12 X |
| Target Price | 197.56 | |
| Number Of Employees | 1.24 K | 18.84 K |
| Beta | 1.67 | -0.15 |
| Market Capitalization | 5.23 B | 19.03 B |
| Z Score | 43.8 | 8.72 |
10X GENOMICS Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as 10X . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 14.11 | |||
| Day Typical Price | 14.11 | |||
| Price Action Indicator | (0.25) | |||
| Period Momentum Indicator | (0.49) | |||
| Relative Strength Index | 66.23 |
About 10X GENOMICS Buy or Sell Advice
When is the right time to buy or sell 10X GENOMICS DL? Buying financial instruments such as 10X Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having 10X GENOMICS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Growth Funds Thematic Idea Now
Small Growth Funds
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in 10X Stock
10X GENOMICS financial ratios help investors to determine whether 10X Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 10X with respect to the benefits of owning 10X GENOMICS security.